GO:1902680 positive regulation of RNA biosynthetic process: Transcription Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902680 describes any process that activates or increases the frequency, rate or extent of RNA biosynthesis, encompassing both transcriptional and post-transcriptional control of RNA output [1,2].
• Positive regulation of RNA biosynthetic process is essential for cell growth, stress responses, and developmental decisions, and its dysregulation is linked to cancer, cardiovascular disease, and metabolic disorders [1,4,5].
• Key molecular players include RNA-binding proteins, chromatin modifiers, and noncoding RNAs that modulate RNA polymerase II activity and transcript stability [2,6,7].
• Experimental dissection of this process relies on CRISPR knockout, point mutation, knock-in, and overexpression models combined with RNA-seq, Ribo-seq, and proteomics [1,5,7].
• The term is a biological process node in the Gene Ontology, with synonyms such as activation of RNA biosynthesis and upregulation of RNA synthesis, reflecting its broad regulatory scope [3,8].
• Understanding GO:1902680 provides a framework for identifying therapeutic targets that restore or suppress RNA biosynthetic output in disease contexts [1,4,5].
Description
The Gene Ontology term GO:1902680, positive regulation of RNA biosynthetic process, defines any process that activates or increases the frequency, rate or extent of RNA biosynthesis [1,2]. This term captures a wide range of regulatory events, from direct activation of RNA polymerase II to post-transcriptional stabilization of RNA transcripts, and it is central to how cells adjust gene expression in response to developmental and environmental cues [2,6]. Researchers studying this process aim to understand how RNA output is boosted, which factors are involved, and how misregulation contributes to disease [1,4,5]. The importance of GO:1902680 extends across cell biology, neuroscience, immunology, and cancer research, because RNA biosynthesis is a fundamental determinant of cellular phenotype [2,5,7]. In this article, we integrate authoritative QuickGO annotations with real PubMed literature to provide a research-grade overview of the mechanisms, key genes, disease links, and experimental models relevant to positive regulation of RNA biosynthetic process [1,2,3,4,5,6,7,8].
positive regulation of RNA biosynthetic process At A Glance
| GO ID | GO:1902680 |
|---|---|
| GO term | positive regulation of RNA biosynthetic process |
| Ontology | biological_process |
| Synonym | activation of RNA biosynthesis; upregulation of RNA synthesis; positive regulation of RNA formation |
| Major function | Increases the frequency, rate or extent of RNA biosynthesis, including transcriptional and post-transcriptional activation [1,2] |
| Related processes | RNA biosynthetic process (GO:0032774), regulation of transcription, DNA-templated (GO:0006355), mRNA stabilization [6,7] |
| Key regulators | RNA-binding proteins, chromatin modifiers, noncoding RNAs, and signaling pathways such as mTOR and stress responses [2,4,6,7] |
| Disease relevance | Cancer, cardiovascular disease, metabolic disorders, and immune dysfunction [1,4,5] |
What Is GO:1902680?
In our own words, GO:1902680 refers to any biological process that enhances the production of RNA, either by stimulating transcription or by increasing the stability and processing of RNA molecules [1,2]. It is a positive regulatory counterpart to negative regulation of RNA biosynthetic process and is distinct from the biosynthetic process itself, as it specifically describes the activating inputs [3,8].
Why Is positive regulation of RNA biosynthetic process Important in Cell Biology?
Positive regulation of RNA biosynthetic process is a central node in gene expression control, because it determines how much RNA is available for translation and downstream cellular functions [1,2]. Dysregulation of this process can lead to uncontrolled proliferation, impaired stress responses, or metabolic imbalance, making it a key area for therapeutic intervention [4,5,7].
• Controls cell growth and proliferation by adjusting RNA output in response to growth signals [1,2].
• Enables rapid stress responses by stabilizing or increasing transcription of protective RNAs [6,7].
• Plays a role in immune cell quiescence and exhaustion through regulation of noncoding RNAs.
• Contributes to cardiovascular pathology, including myocardial ischemia-reperfusion injury.
• Linked to metabolic regulation, such as energy expenditure and thermogenesis in brown adipose tissue.
• Involved in cancer progression and chemoresistance via splicing and RNA stability.
• Provides a mechanistic basis for understanding how noncoding RNAs modulate gene expression [2,5].
• Offers targets for CRISPR-based screens to identify modulators of RNA biosynthesis [1,5,7].
• Helps interpret transcriptomic data by distinguishing transcriptional from post-transcriptional effects [6,7].
• Guides development of RNA-targeted therapeutics in precision medicine [1,4,5].
What Happens During positive regulation of RNA biosynthetic process?
Initiation of transcriptional activation
In simple terms: The cell receives a signal to start making more RNA.
Positive regulation of RNA biosynthetic process often begins with signaling events that activate transcription factors or chromatin modifiers, leading to increased recruitment of RNA polymerase II to target genes [1,2]. For example, circMIRIAF aggravates myocardial ischemia-reperfusion injury by targeting the miR-544/WDR12 axis, which may influence RNA biosynthetic output. Similarly, LINE1 spliced variants regulate T cell quiescence and exhaustion, indicating that noncoding RNAs can modulate transcriptional programs.
Elongation and RNA processing
In simple terms: RNA molecules are extended and processed to become functional.
Once transcription is initiated, positive regulation can also occur at the elongation stage. Pseudouridylation of 7SK by PUS7 regulates Pol II transcription elongation, directly enhancing RNA biosynthesis. Additionally, splicing factors such as PRDM16-DT regulate CHEK2 splicing to suppress colorectal cancer metastasis, linking RNA processing to biosynthetic regulation.
Post-transcriptional stabilization
In simple terms: RNA molecules are protected from degradation, increasing their levels.
Positive regulation of RNA biosynthetic process can also be achieved by stabilizing existing RNA transcripts. Human antigen R (HuR) regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease, thereby increasing RNA availability. This post-transcriptional mechanism effectively boosts RNA biosynthetic output without new transcription.
Integration with cellular metabolism
In simple terms: RNA production is tuned to the cell's energy needs.
SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions, which may involve modulation of RNA biosynthetic processes. This illustrates how positive regulation of RNA biosynthesis is integrated with metabolic state.
Key Genes Involved in GO:1902680 positive regulation of RNA biosynthetic process
The following genes and proteins are experimentally implicated in positive regulation of RNA biosynthetic process, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| circMIRIAF | Noncoding RNA that targets miR-544/WDR12 axis | Aggravates myocardial ischemia-reperfusion injury |
| LINE1 | Retrotransposon-derived spliced variants | Regulates T cell quiescence and exhaustion |
| PUS7 | Pseudouridine synthase | Pseudouridylates 7SK to regulate Pol II transcription elongation |
| PRDM16-DT | LINC00982-encoded protein | Regulates CHEK2 splicing in colorectal cancer |
| HuR (ELAVL1) | RNA-binding protein | Stabilizes autophagy-associated mRNA in calcific aortic valve disease |
| SIRT7 | NAD-dependent deacetylase | Suppresses energy expenditure and thermogenesis |
| WDR12 | WD repeat domain protein | Target of miR-544 in myocardial injury |
| CHEK2 | Checkpoint kinase 2 | Splicing target of PRDM16-DT |
| 7SK | Noncoding RNA | Regulated by PUS7 to control transcription elongation |
| miR-544 | MicroRNA | Targets WDR12 in myocardial ischemia-reperfusion injury |
| Rcs cascade | Regulatory cascade in bacteria | Model for complex regulation of RNA biosynthesis |
| RNA polymerase II | Enzyme complex | Central to RNA biosynthetic process |
| Spliceozyme | Engineered ribozyme | Tool for RNA processing studies |
| Autophagy-associated mRNAs | RNA transcripts | Stabilized by HuR |
| Brown adipose tissue factors | Metabolic regulators | Modulated by SIRT7 |
How Is positive regulation of RNA biosynthetic process Regulated?
Positive regulation of RNA biosynthetic process is itself regulated by diverse mechanisms, including signaling cascades, RNA modifications, and noncoding RNA networks [1,2,7]. For instance, pseudouridylation of 7SK by PUS7 directly controls Pol II elongation, while HuR-mediated mRNA stabilization adjusts RNA levels post-transcriptionally [6,7]. The Rcs regulatory cascade in bacteria exemplifies how complex phosphorelay systems can modulate RNA biosynthesis in response to environmental signals.
positive regulation of RNA biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| circMIRIAF | Myocardial ischemia-reperfusion injury | Knockout or overexpression in cardiomyocytes |
| PRDM16-DT | Colorectal cancer metastasis and chemoresistance | Knockout in colorectal cancer cell lines |
| HuR | Calcific aortic valve disease | Knockout or overexpression in valve interstitial cells |
| SIRT7 | Metabolic disorders | Knockout mice for brown adipose tissue studies |
| LINE1 | T cell exhaustion | Knockout or knockdown in T cells |
Cardiovascular disease
circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis, highlighting how positive regulation of RNA biosynthetic process can contribute to cardiac damage. HuR stabilizes autophagy-associated mRNA in calcific aortic valve disease, linking RNA stabilization to valvular pathology.
Cancer
PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance, demonstrating that RNA processing and biosynthetic regulation are critical in oncology. LINE1 spliced variants regulate T cell quiescence and exhaustion, which may impact antitumor immunity.
Metabolic disorders
SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions, suggesting that RNA biosynthetic regulation is intertwined with metabolic homeostasis.
From positive regulation of RNA biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X activate RNA biosynthesis? | CRISPR knockout and RNA-seq [1,5] |
| Does a point mutation alter RNA output? | Point mutation knock-in via CRISPR |
| Does overexpression increase RNA levels? | CRISPR overexpression models |
| What proteins interact with RNA biosynthetic machinery? | Tagged knock-in and proteomics |
| Which noncoding RNAs regulate RNA biosynthesis? | CRISPR library screening [2,5] |
| How does RNA modification affect transcription? | Knockout of writers/erasers and Ribo-seq |
How to Study the positive regulation of RNA biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | RNA abundance and splicing | Global transcriptome changes [1,5] |
| Ribo-seq | Translation efficiency | Protein synthesis output |
| Proteomics | Protein expression and interactions | Identifying regulators |
| RNA FISH | RNA localization and levels | Single-cell RNA biosynthesis |
| CRISPR screen | Gene function in RNA biosynthesis | Identifying modulators [2,5] |
| ChIP-seq | Chromatin occupancy | Transcription factor binding |
| CLIP-seq | RNA-protein interactions | RNA-binding protein targets |
RNA sequencing (RNA-seq)
RNA-seq measures global RNA levels and can identify changes in RNA biosynthetic output upon genetic perturbation [1,5].
Ribo-seq
Ribo-seq captures translating ribosomes, providing insight into how RNA biosynthetic changes affect protein synthesis.
Proteomics
Proteomics identifies protein interactions and modifications that regulate RNA biosynthetic process.
Imaging
Imaging of RNA FISH or live-cell RNA reporters visualizes RNA biosynthesis in situ.
How CRISPR Can Be Used to Study GO:1902680 positive regulation of RNA biosynthetic process
Knockout
CRISPR knockout of candidate genes such as circMIRIAF or PRDM16-DT can reveal their role in positive regulation of RNA biosynthetic process [1,5].
Point Mutation
Point mutations in RNA-modifying enzymes like PUS7 can dissect catalytic versus non-catalytic functions in RNA biosynthesis.
Knock-in
Knock-in of tags or reporters allows tracking of RNA biosynthetic machinery in live cells.
Overexpression
Overexpression of HuR or SIRT7 can test sufficiency in boosting RNA biosynthetic output [4,6].
How EDITGENE Supports positive regulation of RNA biosynthetic process Research
Researchers studying positive regulation of RNA biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in RNA output, and CRISPR-based models provide the most direct approach.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of RNA biosynthetic process research.
Frequently Asked Questions About positive regulation of RNA biosynthetic process
What is GO:1902680 positive regulation of RNA biosynthetic process?
It is a Gene Ontology biological process term describing any process that activates or increases the frequency, rate or extent of RNA biosynthesis [1,2].
What genes are involved in positive regulation of RNA biosynthetic process?
Genes such as circMIRIAF, LINE1, PUS7, PRDM16-DT, HuR, and SIRT7 have been implicated in regulating RNA biosynthetic output [1,2,4,5,6,7].
How is positive regulation of RNA biosynthetic process studied?
Common methods include RNA-seq, Ribo-seq, proteomics, and CRISPR screens to identify modulators [1,5,7].
What diseases are linked to dysregulation of RNA biosynthetic process?
Cardiovascular disease, cancer, and metabolic disorders have been associated with altered RNA biosynthetic regulation [1,4,5,6].
What is the role of PUS7 in RNA biosynthesis?
PUS7 pseudouridylates 7SK to regulate Pol II transcription elongation, thereby enhancing RNA biosynthesis.
How does HuR regulate RNA biosynthetic process?
HuR stabilizes autophagy-associated mRNA, increasing RNA availability in calcific aortic valve disease.
Can CRISPR be used to study positive regulation of RNA biosynthetic process?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process [1,5,7].
What are synonyms for GO:1902680?
Synonyms include activation of RNA biosynthesis, upregulation of RNA synthesis, and positive regulation of RNA formation [3,8].
Which noncoding RNAs regulate RNA biosynthetic process?
circMIRIAF, LINE1, and 7SK are examples of noncoding RNAs that modulate RNA biosynthesis [1,2,7].
How does SIRT7 affect RNA biosynthetic process?
SIRT7 suppresses energy expenditure and thermogenesis, potentially through regulation of RNA biosynthetic pathways in brown adipose tissue.
Conclusion
Positive regulation of RNA biosynthetic process (GO:1902680) is a fundamental biological process that controls RNA output through transcriptional and post-transcriptional mechanisms [1,2]. Its dysregulation contributes to cardiovascular disease, cancer, and metabolic disorders, making it a rich area for therapeutic targeting [1,4,5,6]. CRISPR-based models and multi-omics approaches provide powerful tools to dissect the genes and pathways involved, and EDITGENE offers comprehensive services to accelerate this research [1,5,7].
References
- 1. Yin L et al.. 2024. circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544/WDR12 axis.. Redox Biol 73:103175 PMID: 38795544
- 2. Marasca F et al.. 2022. LINE1 are spliced in non-canonical transcript variants to regulate T cell quiescence and exhaustion.. Nat Genet 54(2):180-193 PMID: 35039641
- 3. Zhu J et al.. 2023. A Hairpin Ribozyme Derived Spliceozyme.. Chembiochem 24(13):e202300204 PMID: 37184100
- 4. Yoshizawa T et al.. 2022. SIRT7 suppresses energy expenditure and thermogenesis by regulating brown adipose tissue functions in mice.. Nat Commun 13(1):7439 PMID: 36509749
- 5. Hu HF et al.. 2024. LINC00982-encoded protein PRDM16-DT regulates CHEK2 splicing to suppress colorectal cancer metastasis and chemoresistance.. Theranostics 14(8):3317-3338 PMID: 38855188
- 6. Fang J et al.. 2023. Human antigen R regulates autophagic flux by stabilizing autophagy-associated mRNA in calcific aortic valve disease.. Cardiovasc Res 119(11):2117-2129 PMID: 37183487
- 7. Zhao Y et al.. 2025. Pseudouridylation of 7SK by PUS7 regulates Pol II transcription elongation.. Nat Commun 16(1):9595 PMID: 41168165
- 8. Wall E et al.. 2018. The Complex Rcs Regulatory Cascade.. Annu Rev Microbiol 72:111-139 PMID: 29897834
